2017 to 2020 Saw No Change in Pediatric Psychiatric Bed Capacity
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 19, 2024 -- From 2017 to 2020, there was no change in U.S. pediatric inpatient psychiatric bed capacity, according to a research letter published online Aug. 19 in JAMA Pediatrics.
Anna M. Cushing, M.D., from the Children's Hospital Los Angeles, and colleagues characterized geographic variation in pediatric inpatient psychiatric beds in the United States from 2017 to 2020. Changes in hospitals with pediatric inpatient psychiatric beds and overall bed counts were estimated using linear regression.
The researchers found that 421 of the 6,347 hospitals in the American Hospital Association Survey Database provided at least two pediatric inpatient psychiatric beds between 2017 and 2020. Between 2017 and 2020, there was no significant change seen in hospitals with pediatric inpatient psychiatric beds (398 versus 400) or national pediatric inpatient psychiatric bed capacity (11,107 versus 11,276). In 2020, most hospitals with pediatric inpatient psychiatric beds were urban (88.8 percent of 400), representing 91.3 percent of bed capacity. Overall, 52.2 and 23.0 percent of the 11,276 beds were in free-standing psychiatric hospitals and hospitals specializing in pediatric care, respectively. The median number of pediatric inpatient psychiatric beds was 15 per 100,000 children across states and varied from 0 to 75 from Alaska to Arkansas. Associations with fewer beds per capita were seen for higher statewide median household income and a higher percentage Hispanic population.
"Attention is needed to ensure national pediatric inpatient psychiatric capacity is sufficient to meet population mental health needs and that resources are equitably distributed," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-20 01:15
Read more
- Racial, Gender, Socioeconomic Disparities Seen in Teen Alcohol, Drug Screening
- Can Cannabis Change Your Brain? Maybe, Maybe Not
- Being Born Preterm Tied to Lifelong Harms in Employment, Education
- COVID-19 Pandemic-Linked Increase in Alcohol Use Persisting
- FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
- Avadel Pharmaceuticals Announces FDA Approval of Lumryz (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions